"10.1371_journal.pone.0039588","plos one","2012-06-18T00:00:00Z","Ying-Hua Li; Xiaoxu Wang; Yunfeng Pan; Dong-Hyun Lee; Dipanjan Chowdhury; Alec C Kimmelman","Division of Genomic Stability and DNA Repair, Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States of America","Conceived and designed the experiments: YL DC ACK. Performed the experiments: YL XW YP DL. Analyzed the data: YL DC ACK. Wrote the paper: YL AK.","ACK is a Consultant for Forma Therapeutics and for Dainippon Pharma. He has received research funding from Karyopharm therapeutics for an unrelated project and has received a speaking honorarium from Pfizer. There are no patents, products in development or marketed products to declare. This does not alter our adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2012","06","Ying-Hua Li","YHL",6,TRUE,3,4,3,2,TRUE,TRUE,FALSE,0,NA,FALSE
